Member Info for CashFlow66

Seems someones 14.38K Shares were triggered and traded at 57.50.

I often wonder if the Glitch that happened this morning which dropped the price to 57.50 are done deliberately. It's the second time this as happened on Rene within 2 months. This must have trigger lot of stop losses.

The Link works fine what issue are you having?

Hi Badeli - I have heard from others that Freddie is still around on other Forums. You are right he was the most optrmistic Rene trader. People like PurpleAckee (Pro Deramper) really abused him on here and now remains quiet as the results now prove he was here to Deramp the share. Personally he did me a great favour as I bought in when the share dived.

A few links mentioning Rene in the USA. We have fingers in many different pies and all have vast potential to be very profitable.

https://thetokenclock.com/global-critical-limb-ischemia-drug-market-2019-reneuron-group-plc-symic-biomedical-inc-tikomed-ab-u-s-stem-cell-inc-kasiak-research-pvt-ltd/

https://westminsternewsonline.com/4793/rheumatoid-arthritis-stem-cell-therapy-market-forecast-research-reports-offers-key-insights-2018-2028

https://selectbiosciences.com/conferences/index.aspx?conf=EVTC2019

popes - I was told by someone on here that he was Live and kicking posting on other Forums.

Stifel target 625p N+1 Singer target 900p Edison target 608p

100+ today easy.

And we're off! Upwards she goes...

A massive £303.18K late Cash Trade went through. Roll on Tomorrow.

Is that a qualified "I don't think that's long enough" or a hunch?

Mcleod your exactly right. Anyone with an ounce of sense knows at these prices its worth more than a punt. Most of the LSE is struggling due to Brexit and Rene is 20% up. Definitely something Brewing IMO.

Interesting post I spotted elsewhere...

Super - they have put up the slides. There is more detail regarding the most recent retinal results. Looks like patient 1 may have peaked at day 30 and then seen a small decline. It will be interesting to see if that patient remains stable at around +20 letter improvement. They have all improved at different rates. More data is needed. Still impressive. hTTp://4965zs3ha2l125fk78zkozo3.wpengine.netdna-cdn.com/wp-content/uploads/ReNeuron-corporate-presentation-Mar-2019.pdf My other thought on this Presentation is that they are now leading with the Retinal part of the business. I think this will be the value driver in the near term and potentially long term. The opportunity in other retinal indications must be huge if they can replicate the initial success shown. Regeneron's drug called Eylea generates 4 billion dollars in annual revenue to just stabilise macular degeneration.

Personally I take charting with a pinch of salt. IMO It's similar to the form papers on the walls of every bookmakers shop in the country. Many times an odds on Favourite is shown to be unbeatable then loses the race, taking many a punters wages with it too.
Until a chart can predict a devastating RNS announcement or the Brexit outcome, i'll stay far away from them.
This of course IMO and I hope I don't offend any that swear by them.

We appear to be missing 8.5% of the shares Invesco sold. Ali Mortazavi may still be increasing his stake and other private shareholders are clearly buying. However it does suggest there may be another yet unidentified buyer out there.

Hope this helps.

http://www.lse.co.uk/AllNews.asp?code=h0gbeuny&headline=Invesco_Exits_Its_10_Stake_In_Biotech_Firm_ReNeuron_In_Transaction_ALLISS

In my books that's positive news. Rene has a lot of potential and slowly but surely the market is realising it. Blink and you'll miss a massive opportunity to make a lot of money.

Lol Cadbury I heard you the first time. Another one with fat fingers I see.

Definitely Edwards fat fingers as it’s 89p and upwards she goes.

I saw that on my phone and assumed it was a Blip of some sort as it went back to 80 straight away.